Literature DB >> 29337437

Canonical signaling and nuclear activity of mTOR-a teamwork effort to regulate metabolism and cell growth.

Vincent Giguère1.   

Abstract

Mechanistic (or mammalian) target of rapamycin (mTOR) is a kinase that regulates almost all functions related to cell growth and metabolism in response to extra- and intracellular stimuli, such as availability of nutrients, the presence of growth factors, or the energy status of the cell. As part of two distinct protein complexes, mTORC1 and mTORC2, the kinase has been shown to influence cell growth and proliferation by controlling ribosome biogenesis, mRNA translation, carbohydrate and lipid metabolism, protein degradation, autophagy as well as microtubule and actin dynamics. In addition to these well-characterized functions, mTOR can also influence gene transcription. While most studies focused on investigating how canonical mTOR signaling regulates the activity of transcription factors outside the nucleus, recent findings point to a more direct role for mTOR as a transcription factor operating on chromatin in the nucleus. In particular, recent genome-wide identification of mTOR targets on chromatin reveals that its activities in the nucleus and cytoplasm are functionally and biologically linked, thus uncovering a novel paradigm in mTOR function.
© 2018 Federation of European Biochemical Societies.

Entities:  

Keywords:  ChIP sequencing; autophagy; gene expression; growth factor; lipogenesis; nuclear mTOR; nuclear receptor; nutrient; protein degradation; transcription; translation

Mesh:

Substances:

Year:  2018        PMID: 29337437     DOI: 10.1111/febs.14384

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  22 in total

Review 1.  Advances in the role of exosomal non-coding RNA in the development, diagnosis, and treatment of gastric cancer (Review).

Authors:  Peng-Fei Gao; Da Huang; Jun-Yan Wen; Wei Liu; Hong-Wu Zhang
Journal:  Mol Clin Oncol       Date:  2020-06-10

Review 2.  Transcriptional control of energy metabolism by nuclear receptors.

Authors:  Charlotte Scholtes; Vincent Giguère
Journal:  Nat Rev Mol Cell Biol       Date:  2022-05-16       Impact factor: 113.915

Review 3.  The Multifaceted Role of Nutrient Sensing and mTORC1 Signaling in Physiology and Aging.

Authors:  Stephanie A Fernandes; Constantinos Demetriades
Journal:  Front Aging       Date:  2021-08-27

4.  Regulation of nuclear mTORC1.

Authors:  Xin Zhou; Yanghao Zhong; Jin Zhang
Journal:  Mol Cell Oncol       Date:  2021-05-05

5.  Nutrient availability contributes to a graded refractory period for regeneration in Xenopus tropicalis.

Authors:  Madison C Williams; Jeet H Patel; Anneke D Kakebeen; Andrea E Wills
Journal:  Dev Biol       Date:  2021-01-20       Impact factor: 3.582

6.  GNG7 silencing promotes the proliferation and differentiation of placental cytotrophoblasts in preeclampsia rats through activation of the mTOR signaling pathway.

Authors:  Wei-Si Lai; Yi-Ling Ding
Journal:  Int J Mol Med       Date:  2019-03-12       Impact factor: 4.101

7.  The p52 isoform of SHC1 is a key driver of breast cancer initiation.

Authors:  Kevin D Wright; Bradley S Miller; Sarah El-Meanawy; Shirng-Wern Tsaih; Anjishnu Banerjee; Aron M Geurts; Yuri Sheinin; Yunguang Sun; Balaraman Kalyanaraman; Hallgeir Rui; Michael J Flister; Andrey Sorokin
Journal:  Breast Cancer Res       Date:  2019-06-15       Impact factor: 6.466

8.  Lack of muscle mTOR kinase activity causes early onset myopathy and compromises whole-body homeostasis.

Authors:  Qing Zhang; Agnès Duplany; Vincent Moncollin; Sandrine Mouradian; Evelyne Goillot; Laetitia Mazelin; Karine Gauthier; Nathalie Streichenberger; Céline Angleraux; Jie Chen; Shuzhe Ding; Laurent Schaeffer; Yann-Gaël Gangloff
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-11-21       Impact factor: 12.910

Review 9.  Nuclear Functions of TOR: Impact on Transcription and the Epigenome.

Authors:  R Nicholas Laribee; Ronit Weisman
Journal:  Genes (Basel)       Date:  2020-06-10       Impact factor: 4.096

10.  Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.

Authors:  Ji Yeon Son; Sungpil Yoon; In Hwan Tae; Yu Jin Park; Umasankar De; Yukyoung Jeon; Young Ju Park; Im Joo Rhyu; Byung Mu Lee; Kyu-Huck Chung; Joung Eun Lim; Se Jeong Lee; Hye Won Lee; Jong Hwan Kwak; Hyung Sik Kim; Han Yong Choi
Journal:  Cancer Med       Date:  2018-08-29       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.